CID 131765213
1-adrenoyl-2-myristoyl-3-osbondoyl-glycerol
Structural Information
- Molecular Formula
- C61H100O6
- SMILES
- CCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC
- InChI
- InChI=1S/C61H100O6/c1-4-7-10-13-16-19-22-24-26-28-30-32-34-36-39-41-44-47-50-53-59(62)65-56-58(67-61(64)55-52-49-46-43-38-21-18-15-12-9-6-3)57-66-60(63)54-51-48-45-42-40-37-35-33-31-29-27-25-23-20-17-14-11-8-5-2/h16-17,19-20,24-27,30-33,36-37,39-40,44,47,58H,4-15,18,21-23,28-29,34-35,38,41-43,45-46,48-57H2,1-3H3/b19-16-,20-17-,26-24-,27-25-,32-30-,33-31-,39-36-,40-37-,47-44-/t58-/m1/s1
- InChIKey
- TZFHAEVKUDZTRA-WOOVGWQQSA-N
- Compound name
- [(2S)-3-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-tetradecanoyloxypropyl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 929.75928 | 326.2 |
[M+Na]+ | 951.74122 | 328.3 |
[M+NH4]+ | 946.78582 | 328.2 |
[M+K]+ | 967.71516 | 332.1 |
[M-H]- | 927.74472 | 312.4 |
[M+Na-2H]- | 949.72667 | 321.4 |
[M]+ | 928.75145 | 324.1 |
[M]- | 928.75255 | 324.1 |
Literature stripe
Patent stripe
No patent data available for this compound.